278 related articles for article (PubMed ID: 16585598)
1. Histone hyperacetylation is associated with amelioration of experimental colitis in mice.
Glauben R; Batra A; Fedke I; Zeitz M; Lehr HA; Leoni F; Mascagni P; Fantuzzi G; Dinarello CA; Siegmund B
J Immunol; 2006 Apr; 176(8):5015-22. PubMed ID: 16585598
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice.
Glauben R; Batra A; Stroh T; Erben U; Fedke I; Lehr HA; Leoni F; Mascagni P; Dinarello CA; Zeitz M; Siegmund B
Gut; 2008 May; 57(5):613-22. PubMed ID: 18194985
[TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
4. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
Barbetti V; Gozzini A; Cheloni G; Marzi I; Fabiani E; Santini V; Dello Sbarba P; Rovida E
Epigenetics; 2013 Feb; 8(2):210-9. PubMed ID: 23321683
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
7. An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice.
Do A; Reid RC; Lohman RJ; Sweet MJ; Fairlie DP; Iyer A
J Pharmacol Exp Ther; 2017 Jan; 360(1):140-151. PubMed ID: 27827303
[TBL] [Abstract][Full Text] [Related]
8. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
[TBL] [Abstract][Full Text] [Related]
9. Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.
Facchetti F; Previdi S; Ballarini M; Minucci S; Perego P; La Porta CA
Apoptosis; 2004 Sep; 9(5):573-82. PubMed ID: 15314285
[TBL] [Abstract][Full Text] [Related]
10. MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells.
Imesch P; Dedes KJ; Furlato M; Fink D; Fedier A
Int J Oncol; 2009 Sep; 35(3):631-40. PubMed ID: 19639184
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo.
Glauben R; Sonnenberg E; Wetzel M; Mascagni P; Siegmund B
J Biol Chem; 2014 Feb; 289(9):6142-51. PubMed ID: 24421314
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
[TBL] [Abstract][Full Text] [Related]
13. Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009.
Hsieh IN; Liou JP; Lee HY; Lai MJ; Li YH; Yang CR
Cell Death Dis; 2014 Apr; 5(4):e1166. PubMed ID: 24722291
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.
Kulp SK; Chen CS; Wang DS; Chen CY; Chen CS
Clin Cancer Res; 2006 Sep; 12(17):5199-206. PubMed ID: 16951239
[TBL] [Abstract][Full Text] [Related]
15. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
Leng Y; Chuang DM
J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
[TBL] [Abstract][Full Text] [Related]
16. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons.
Fujiki R; Sato A; Fujitani M; Yamashita T
Cell Death Dis; 2013 Jun; 4(6):e677. PubMed ID: 23788034
[TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid, a novel histone deacetylase inhibitor, improves the development and acetylation level of miniature porcine handmade cloning embryos.
Sun JM; Cui KQ; Li ZP; Lu XR; Xu ZF; Liu QY; Huang B; Shi DS
Reprod Domest Anim; 2017 Oct; 52(5):763-774. PubMed ID: 28432707
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylases in inflammatory bowel diseases.
Glauben R; Siegmund B
Mol Med; 2011; 17(5-6):426-33. PubMed ID: 21365125
[TBL] [Abstract][Full Text] [Related]
19. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
20. Molecular sequelae of histone deacetylase inhibition in human malignant B cells.
Mitsiades N; Mitsiades CS; Richardson PG; McMullan C; Poulaki V; Fanourakis G; Schlossman R; Chauhan D; Munshi NC; Hideshima T; Richon VM; Marks PA; Anderson KC
Blood; 2003 May; 101(10):4055-62. PubMed ID: 12531799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
